Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Phlyctochytrium bullatum strain:JEL0754

ABSTRACT: Phlyctochytrium bullatum JEL0754 Resequencing genome sequencing

PROVIDER: PRJNA619743 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Methylobacterium bullatum strain:RSE8.43

Project description:Whole Genome sequencing of Methylobacterium bullatum RSE8.43

| PRJNA278348 | ENA

Methylobacterium bullatum strain:RSE8.46

Project description:Whole Genome sequencing of Methylobacterium bullatum RSE8.46

| PRJNA278351 | ENA

Methylobacterium bullatum strain:RSE8.44

Project description:Whole Genome sequencing of Methylobacterium bullatum RSE8.44

| PRJNA278349 | ENA

Methylobacterium bullatum strain:RSE8.45

Project description:Whole Genome sequencing of Methylobacterium bullatum RSE8.45

| PRJNA278350 | ENA

Methylobacterium bullatum

Project description:Methylobacterium bullatum overview

| PRJNA307462 | ENA

Methylobacterium bullatum strain:LMG 24788

Project description:Whole genome sequencing of Methylobacterium bullatum LMG 24788

| PRJNA392849 | ENA

Phlyctochytrium planicorne strain:JEL0388

Project description:Phlyctochytrium planicorne JEL0388 Resequencing genome sequencing

| PRJNA619744 | ENA

Phlyctochytrium arcticum strain:BR59

Project description:Triparticalcar arcticum BR59 Standard Draft genome sequencing

| PRJNA463939 | ENA

Mechanisms of hepatic steatosis in chickens: integrated analysis of the host genome, molecular phenomes and gut microbiome

Project description:Hepatic steatosis is the initial manifestation of abnormal liver functions and often leads to liver diseases such as non-alcoholic fatty liver disease in humans and fatty liver syndrome in animals. In this study, we conducted a comprehensive analysis of a large chicken population consisting of 705 adult hens by combining host genome resequencing, liver transcriptome, proteome, and metabolome analysis, as well as microbial 16S rRNA gene sequencing of each gut segment.

2024-04-09 | PXD042451 | Pride

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data